HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boldt, J. Articles by Hempelmann, G. Search for Related Content PubMed PubMed Citation Articles by Boldt, J. Articles by Hempelmann, G.

The Annals of Thoracic Surgery, Vol 55, 1460-1466, Copyright © 1993 by The Society of Thoracic Surgeons

ARTICLES

Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood

J Boldt, C Knothe, B Zickmann, N Wege, F Dapper and G Hempelmann
Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig- University Giessen, Germany.

Excessive hemorrhage secondary to cardiopulmonary bypass may be encountered after pediatric cardiac operations. Platelet dysfunction appears to be especially responsible for this problem. The proteinase inhibitor aprotinin is suggested to possess platelet preservation properties and reduce blood loss in this situation. The effects of aprotinin (25,000 U/kg after induction of anesthesia, 25,000 U/kg added to the prime, 25,000 U/kg every hour of cardiopulmonary bypass) on platelet function were randomly studied in 12 children with a weight of less than 10 kg (group 2) and 12 children weighing more than 10 kg (group 4), who were compared with two groups of children without aprotinin (group 1, < 10 kg; group 3, > 10 kg). Twelve children undergoing major vessel operations without cardiopulmonary bypass and aprotinin served as a control. Platelet function was assessed using aggregometry (turbidometric technique with adenosine diphosphate, 2.0 mumol/L; collagen, 4 micrograms/mL; epinephrine, 25 mumol/L; NaCl [control]). Platelet function was not altered in the control patients within the entire investigation period. Maximum aggregation in the small children was already lower at baseline in comparison with that of the children > 10 kg. Cardiopulmonary bypass was followed by a significant reduction in platelet aggregation in all groups. Treatment with aprotinin did not improve platelet function (maximum aggregation and maximum gradient of aggregation) in any group. On the first postoperative day, maximum aggregation in the small children exceeded baseline values, whereas in both groups of children > 10 kg baseline values had almost been established. Postoperative blood loss was not reduced by treatment with aprotinin.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. P. Eaton Antifibrinolytic Therapy in Surgery for Congenital Heart Disease Anesth. Analg., April 1, 2008; 106(4): 1087 - 1100. [Abstract] [Full Text] [PDF]

				E. B. Mossad, S. Machado, and J. Apostolakis Bleeding following deep hypothermia and circulatory arrest in children. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 34 - 46. [Abstract] [PDF]

				D. M. Arnold, D. A. Fergusson, A. K.C. Chan, R. J. Cook, G. A. Fraser, W. Lim, M. A. Blajchman, and D. J. Cook Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth. Analg., March 1, 2006; 102(3): 731 - 737. [Abstract] [Full Text] [PDF]

				W. C. Oliver Jr, D. N. Fass, G. A. Nuttall, J. A. Dearani, L. M. Schrader, D. R. Schroeder, M. H. Ereth, and F. J. Puga Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1670 - 1677. [Abstract] [Full Text] [PDF]

				W. C. Oliver Jr, F. M. Beynen, G. A. Nuttall, D. R. Schroeder, M. H. Ereth, J. A. Dearani, and F. J. Puga Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime Ann. Thorac. Surg., May 1, 2003; 75(5): 1506 - 1512. [Abstract] [Full Text] [PDF]

				J. M. Costello, C. L. Backer, A. de Hoyos, H. J. Binns, and C. Mavroudis Aprotinin reduces operative closure time and blood product use after pediatric bypass Ann. Thorac. Surg., April 1, 2003; 75(4): 1261 - 1266. [Abstract] [Full Text] [PDF]

				E. R. Stephenson Jr and J. L. Myers Pediatric cardiopulmonary bypass Ann. Thorac. Surg., December 1, 2001; 72(6): 2176 - 2177. [Full Text] [PDF]

				H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF]

				A. K Biswas, L. Lewis, and J. F Sommerauer Aprotinin in the management of life-threatening bleeding during extracorporeal life support Perfusion, May 1, 2000; 15(3): 211 - 216. [Abstract] [PDF]

				San Antonio, California abstracts Perfusion, March 1, 1999; 14(2): 149 - 155. [PDF]

				F. Ichinose, S. Uezono, R. Muto, H. Uchida, F. Hatori, K. Terui, Y. Niimi, T. Goto, Y. Nakata, and S. Morita Platelet Hyporeactivity in Young Infants During Cardiopulmonary Bypass Anesth. Analg., February 1, 1999; 88(2): 258 - 258. [Abstract] [Full Text] [PDF]

				G. D. Williams, S. L. Bratton, E. C. Riley, and C. Ramamoorthy Association between age and blood loss in children undergoing open heart operations Ann. Thorac. Surg., September 1, 1998; 66(3): 870 - 875. [Abstract] [Full Text] [PDF]

				J. Guay and J.-F. Hardy Invited commentary Ann. Thorac. Surg., September 1, 1998; 66(3): 875 - 876. [Full Text] [PDF]

				B. E. Miller, S. R. Tosone, V. K.H. Tam, K. R. Kanter, N. A. Guzzetta, J. M. Bailey, and J. H. Levy Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations Ann. Thorac. Surg., August 1, 1998; 66(2): 535 - 540. [Abstract] [Full Text] [PDF]

				T. P. Carrel, M. Schwanda, P. R. Vogt, and M. I. Turina Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Ann. Thorac. Surg., July 1, 1998; 66(1): 153 - 158. [Abstract] [Full Text] [PDF]

				P. Pouard Review of Efficacy Parameters Ann. Thorac. Surg., June 1, 1998; 65(90060): S40 - 44. [Abstract] [Full Text] [PDF]

				B. Blauhut, W. Harringer, P. Bettelheim, J. E. Doran, P. Spath, and P. Lundsgaard-Hansen Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1083 - 1091. [Abstract] [Full Text]